NF-κB-mediated EMT process contributes to HCC progression, and the suppression of the NF-κB pathway represses EMT and invasion of tumor cells (Song et al., 2014; Zhu et al., 2016). This evidence concerns the gene NFKB1 and hepatocellular carcinoma.